International Clinical Trial: A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)

Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07133633) titled 'A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)' on Aug. 14.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Care Provider, Investigator).

Primary Sponsor: Merck Sharp & Dohme LLC

Condition: Radiographic Axial Spondyloarthritis

Intervention: Drug: Tulisokibart

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: September 18, 2025

Target Sample Size: 315

To know more, visit https://clinicaltrials.gov/ct2/show/NC...